CDEK
← All drugs Report issue

t-900607

Small moleculeexperimental

Clinical trial activity

6 trials · 3 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
6
Phase 3
0
Phase 4
0

Earliest trial started Jul 1, 2002 (NCT00043459)

Timeline

2000s

  1. Jan 1, 2002

    Earliest Phase 2 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

COc1ccc(NS(=O)(=O)c2c(F)c(F)c(F)c(F)c2F)cc1NC(N)=O
Mol. weight
411.31 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Achiral Molecule
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • t900607
  • t900607
  • t900607
  • t 900607
  • t-900607
  • t-900607

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT00054262Phase 2Nov 1, 2002Case Western Reserve University, National Cancer Institute (NCI)
NCT00048529Phase 2Sep 1, 2002Tularik
NCT00054249Phase 2Sep 1, 2002Case Western Reserve University, National Cancer Institute (NCI)
NCT00043433Phase 2Jul 1, 2002Tularik
NCT00043446Phase 2Jul 1, 2002Tularik
NCT00043459Phase 2Jul 1, 2002Tularik
Showing 6 of 6 trials
Page 1 / 1

Organizations

Research & Development (3)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
TularikFor profit4412002
Case Western Reserve UniversityAcademic/Hospital2212002
National Cancer Institute (NCI)Government2012002
3 organizations
Page 1 / 1